RESMED INC · Surgical & Medical Instruments & Apparatus

RMD

Low riskNext report: In 2 days (est.)

View price ↗

The short version

A high-quality, profitable business with steady sales.

Going well

Profitable every year for 10 years
Brings in more cash than it spends
Little debt

Money moves

Insiders sold $1.2M in the last 30 days, all through pre-planned sales
Institutions added 2.7% to their holdings in the quarter ending June 2026 (387 bought, 492 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$253.24+0.2% that day

Company value: $36.5B; Share price times all shares
Price vs profit (P/E): 24.3x; You pay about $24 for each $1 of yearly profit
Price vs sales: 6.5x; Company value is 6.5 times a year of sales
Dividend yield: 0.8%; Yearly dividend as a share of today's price
Cash vs value: 4%; Cash as a share of company value
Debt vs value: 1%; Debt as a share of company value

From RMD's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26 (worked out from yearly totals)

$1.5B+8.6% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $5.7B, up 9.9% from the 12 months before. Over 5 years, sales grew about 12% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of RMD. Starting points are the company's recent numbers.

Sales growth+10% a yearRecently: +9.9% a yearProfit margin27%Last 12 months: 26.9%P/E at the end24xToday: 24.3x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$9.1B

Profit in 5 years$2.5B

Price these guesses point to$409.01+62% vs $253.24 todayAbout +10% a year, before dividends

What today's price needs: with a 27% margin and a 24x P/E, sales could shrink about 0.1% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

7/7Strong

PassReturn on equity 15%+Earns a lot on the money owners have in the business.24.2%
PassDebt under half of equityNot relying on borrowed money.0.06x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.27.2%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$1.7B
PassShare count not growingNot diluting owners. Falling means buybacks.+0.2% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.59.4%

Revenue: $5.1B; +9.8% vs prior year
5-year growth: +11.7%/yr; revenue, per year
Total debt: $403.9M; 0.06x equity
Current ratio: 3.06x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 6

Revenue: $1.5B; +8.6% YoY
EPS: $2.64; vs $2.58
Op. margin: 30.7%; -3.0 pts
Gross margin: 58.8%; -2.0 pts
Free cash flow: $403.5M
Share count: -1.5%; vs a year ago

Some values are worked out from year-to-date totals in the annual report.

Insider rating

Last 90 days

45Mixed

Pre-planned sales of $1.2M (weaker signal)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

53/ 100

This week: 2
Normal week: 1.8
vs normal: 1.1x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady+2.7%

Institutions added 2.7% to their holdings. 387 bought, 492 sold.

Shares held by institutions100.0M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-0.6%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

0.1x · $399.4M debt

Shares outstandingLatest reported

144M

Why low risk

Auditor change

Earnings reports

Last 12

Next reportIn 2 days (est.)Estimated from the same quarter last year

Results filedAug 6
Results filedJul 7
Results filedApr 30
Results filedJan 29
Results filedOct 30, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Auditor changeAug 17 · View filing ↗Watch New 5%+ holder (passive)Aug 7 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$1.2M2 insiders, 2 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Michael J RiderGlobal General Counsel	Sell	400	$255.00	$102K	12K	Oct 23Filing ↗
-3.1% of their holdings Pre-planned sale (10b5-1) Filed 3 days after
Michael J. FarrellChairman and CEO	Sell	5K	$226.33	$1.1M	480K	Oct 7Filing ↗
-1% of their holdings Pre-planned sale (10b5-1) Also Director Filed 1 day after